Status:
COMPLETED
End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)
Lead Sponsor:
University of Cincinnati
Conditions:
End Stage Liver Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research study is to see how effective bioelectric impedance analysis (BIA) is in determining body composition (the amount of fat versus muscle in the body) and nutritional status ...
Detailed Description
The aim of this study is to report the validity of mBIA to determine body composition changes pre and post LVP (Large Volume Paracentesis) * 18 years of age or older * Cirrhotic patients with refract...
Eligibility Criteria
Inclusion
- Patients with ESLD requiring LVP.
- Age over 18.
- Ability to provide written informed consent.
Exclusion
- Organ retransplant candidates.
- Patient with use of any investigational agent within 30 days before LVP.
- Pregnant or lactating.
- Patients with non-bioprosthetic heart valves pacemakers, defibrillators, artificial joints, pins, plates, or other types of metal objects in the body.
- Amputations other than fingers or toes.
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00374582
Start Date
September 1 2006
End Date
May 1 2008
Last Update
March 4 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Cincinnati
Cincinnati, Ohio, United States, 45267